Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome

Macia, Manuel; de Alvaro Moreno, Fernando; Dutt, Tina; Fehrman, Ingela; Hadaya, Karine; Gasteyger, Christoph; Heyne, Nils

dc.contributor.author	Heyne, Nils
dc.date.accessioned	2019-05-28T08:06:28Z
dc.date.available	2019-05-28T08:06:28Z
dc.date.issued	2017
dc.identifier.issn	1753-0792
dc.identifier.uri	http://hdl.handle.net/10900/88969
dc.language.iso	en	de_DE
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/ckj/sfw115	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_02363
utue.publikation.seiten	310-319	de_DE
utue.personen.roh	Macia, Manuel
utue.personen.roh	de Alvaro Moreno, Fernando
utue.personen.roh	Dutt, Tina
utue.personen.roh	Fehrman, Ingela
utue.personen.roh	Hadaya, Karine
utue.personen.roh	Gasteyger, Christoph
utue.personen.roh	Heyne, Nils
dcterms.isPartOf.ZSTitelID	Clinical Kidney Journal	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE